CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab for the Treatment of Metastatic Triple-Negative Breast Cancer
Stock Information for Cytodyn Inc
Loading
Please wait while we load your information from QuoteMedia.